Stay updated on ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page.

Latest updates to the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe page shows a revision tag change from v3.5.2 to v3.5.3, indicating a small backend/frontend update without altering the displayed study information.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2; this appears to be an internal site update and does not affect the study details.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision: v3.4.3 was added and the previous revision label v3.4.2 was removed. This update is a minor maintenance change and does not affect study details.SummaryDifference0.0%

- Check91 days agoChange DetectedRevision: v3.4.2 was added. The previous government funding-status notice and Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check98 days agoChange DetectedAdded a system-wide notice about a lapse in government funding affecting site updates and directing users to cc.nih.gov and opm.gov for status. Updated the site to version v3.4.1 (from v3.4.0).SummaryDifference0.4%

Stay in the know with updates to ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page.